We have located links that may give you full text access.
Preliminary experience using directional coronary atherectomy for the treatment of acute myocardial infarction.
Journal of Interventional Cardiology 1994 December
Directional coronary atherectomy (DCA) has proven to be an effective treatment for coronary artery disease, both in multiple anatomical locations and in various clinical settings. Little has been published, however, regarding efficacy of DCA for treatment of acute myocardial infarction (MI). This brief report reviews our early experience with DCA in this new role. Twelve patients presenting from April 1993 through February 1994 were identified by review of the DCA Registry at Hamot Medical Center. The group comprised six men and six women mean age 60 years (range 39-81 years). Patients were administered oral aspirin and intravenous nitroglycerin Heparin dose was titrated to maintain ACTs > 300 seconds. DCA was performed using 9.5-, 10-, and 11Fr guiding catheters. Seven Fr EX, 7Fr graft, 7Fr surlyn, and 6Fr EX devices were used. Predilation and/or postdilation with balloon angioplasty was performed when clinically indicated. Postprocedure stenoses were determined using comparable orthogonal angiographic views. Lesions were measured by manual caliper assessment and tissue weights were obtained from all specimens. The procedural success rate was 92% (11/12) and the mean postprocedural diameter stenosis was 15% (range -20% to 52%). The mean tissue weight from atherectomy specimens was 16 mg (range 7.6-35 mg). The mean time from onset of pain to reperfusion was 2.8 hours (range 40 min to 5.5 hours). Clinical success was achieved in 83% (10/12) of patients. Two deaths occurred in patients presenting with cardiogenic shock. Ten patients experienced no ischemic events, heart failure, or arryhthmias following their interventional procedure.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app